Data: 08/08/2026
Total encontrado: 2
1/2US=50 / Câncer
Ma WW, Jimeno A, Choti MA. Advances in the treatment of colorectal cancertargeting receptors of disease. In: Leong SPL, editor. From local invasion to metastatic cancer: involvement of distant sites through the lymphovascular system. New York: Humana Press, 2009. p. 523-32. ISBN 978-1-60327-086-1.

TRATAMENTO DO CANCER COLORECTAL; RECEPTORES DE SEGMENTACAO DE DOENCA; CANCER COLORRETAL; BEVACIZUMAB; CETUXIMAB; PANITUMUMAB; KRAS


2/2Câncer
Pereira ATAR, Chinen LTD, Pinto FAI, Gagliato DM, Santos ES, Maia JML, Assis RJF, Lessa RC, Ribeiro ARG, Formiga MNC, Lima VCC, Mello CA. Cetuximab desensitization protocol in two patients with metastatic colorectal cancer after grade 3 infusion reaction to cetuximab. Applied Cancer Research, São Paulo: Tecmedd, v.32, n.3, p. 95-8, 2012. ISSN 1980-5578.

Disponível em: http://accamargo.phlnet.com.br//applied/ACR2012;32(3)p.95-8.pdf

CETUXIMABE; CANCER COLORECTAL; INFUSAO INTRAVENOSA. EFEITOS ADVERSOS; METASTASES